Abstract

BackgroundRheumatoid arthritis (RA) is related to reduced health related quality of life (HRQL) despite early instituted disease modifying anti rheumatic drugs (DMARD:s) during the 1990's (1).ObjectivesTo analyse differences regarding HRQL...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Health-related quality of life of patients on antiretroviral therapy at the Federal Medical Center, Makurdi, Nigeria
Wasiu Adebimpe ... O Popoola
Libyan International Medical University Journal | VOL. 04
Wasiu Adebimpe, et. al.Wasiu Adebimpe ... O Popoola
01 Jul 2019
Corrleation of health-related quality of life (HRQL) of cancer patients and the mental component parameters of their family members
G Giannopoulos ... I Vrettos
Journal of Clinical Oncology | VOL. 27
G Giannopoulos, et. al.G Giannopoulos ... I Vrettos
20 May 2009
AB0526 ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS USING SF-36 SCALE
R Sarraj ... O Berriche
-
R Sarraj, et. al.R Sarraj ... O Berriche
23 May 2022
Wolff‐Parkinson‐White Syndrome and Atrioventricular Nodal Re‐Entry Tachycardia in a Swedish Population: Consequences on Health‐Related Quality of Life
Magnus Janzon ... Ulla Walfridsson
Pacing and Clinical Electrophysiology | VOL. 32
Magnus Janzon, et. al.Magnus Janzon ... Ulla Walfridsson
25 Sep 2009
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers